Kemper Corp Master Retirement Trust Abb Vie Inc. Transaction History

Kemper Corp Master Retirement Trust

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 11, 2021	SELL	$102.3 - $112.62 $593,340 - $653,196	-5,800 Closed	0 $0
Q4 2020 Feb 11, 2021	SELL	$80.49 - $108.67 $201,225 - $271,675	-2,500 Reduced 30.12%	5,800 $621,000
Q3 2020 Nov 13, 2020	SELL	$85.91 - $100.83 $1.08 Million - $1.27 Million	-12,550 Reduced 60.19%	8,300 $727,000
Q2 2020 Aug 14, 2020	SELL	$73.37 - $98.18 $300,817 - $402,538	-4,100 Reduced 16.43%	20,850 $2.05 Million
Q4 2019 Feb 14, 2020	SELL	$72.13 - $90.25 $613,105 - $767,125	-8,500 Reduced 25.41%	24,950 $2.21 Million
Q3 2018 Nov 13, 2018	SELL	$88.91 - $98.84 $524,569 - $583,156	-5,900 Reduced 14.99%	33,450 $3.16 Million
Q1 2018 May 14, 2018	SELL	$92.01 - $123.21 $179,419 - $240,259	-1,950 Reduced 4.72%	39,350 $3.72 Million
Q2 2017 Aug 15, 2017	BUY	N/A	41,300	41,300 $3 Million

3,891

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $325B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Kemper Corp Master Retirement Trust, based on Form 13F filings with the SEC.

Stay updated on Kemper Corp Master Retirement Trust with notifications on news.